Yasmina Kattou, edited by Gauthier Delomez 6:43 p.m., August 11, 2022

The number of Covid-19 cases has been falling for several weeks, but to anticipate the fall period, which is conducive to an increase in contamination, new vaccines targeting Omicron sub-variants should soon arrive.

Europe 1 provides an update on these vaccines and their date of release on the market.

The Covid-19 epidemic is receding but can start again at any time because of the variants.

France recorded 27,000 cases on Wednesday, a third less than a week ago.

Faced with the risks of recovery, a new vaccine specifically designed for the B.A4 and B.A5 strains of Omicron by the Pfizer laboratory is coming very soon.

If these sub-variants are considered less dangerous, they are transmitted much more easily and this leads to saturation of hospitals.

A situation to avoid for the next waves.

Two new vaccines approved for September

The European Medicines Agency aims to authorize this new serum by the fall, a period when there should be a new peak in contamination.

Ahead of this vaccine, authorities are expected to approve two new vaccines sometime in September.

Pfizer and Moderna have developed a serum with the original Covid strain and Omicron's first subvariant, BA.1.


- Covid: one in eight patients has at least one lasting symptom, according to a study

Finally, to complete the range of vaccines offered, the Ministry of Health confirmed last month the arrival of a French vaccine, Sanofi, and another from the Spanish laboratory Hipra.

Both would be used as a booster dose, but for the moment, no marketing date has been communicated.